Patent · US Active

Human plasma kallikrein inhibitors

US10633345B2 · kind B2 · utility

9Cited by
5References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 2018
Grant dateApr 28, 2020
Priority date—
Expiry dateJun 15, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of formula I

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.